Carlos Casasnovas

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Very early electrodiagnostic findings in Guillain‐Barré syndrome

Maria Alberti, Agustí Alentorn, Sergio Martínez‐Yélamos et al. · Journal of the Peripheral Nervous System · 2011 · 69 citations

Phenotypic spectrum of MFN2 mutations in the Spanish population

Carlos Casasnovas, Isabel Banchs, Julien Cassereau et al. · Journal of Medical Genetics · 2009 · 62 citations

Simultaneous <i>MFN2</i> and <i>GDAP1</i> mutations cause major mitochondrial defects in a patient with CMT

Julien Cassereau, Carlos Casasnovas, Naïg Guéguen et al. · Neurology · 2011 · 38 citations · Full text